Therapy Areas: Autoimmune
19 November 2019 - - The United States Food and Drug Administration has approved US-based pharmaceutical company Pfizer Inc.'s (NYSE: PFE) Abrilada (adalimumab-afzb), as a biosimilar to Humira&nb...
13 November 2019 - - US-based biotechnology company Magenta Therapeutics (NASDAQ: MGTA) has presented new data showing successful immune reset with a single dose of its CD45-ADC in models of three aut...
6 November 2019 - Karo Pharma AB (STO:KARO), a drug research and development company, announced on Tuesday that Pfizer has informed the company about its decision to terminate the specific development...
6 November 2019 - South Korea-based Samsung Biologics has signed a long term contract with United States-based Ichnos Sciences for manufacturing drug substance for ISB 830, an anti-OX40 monoclonal ant...
5 November 2019 - - Israel-based biotechnology company Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI) has initiated its compassionate use programme for Namodenoson in the treatment of hepatocel...
5 November 2019 - Biopharma CMO company Samsung Biologics disclosed on Monday the launch of a long-term agreement with Ichnos Sciences for manufacturing drug substance for ISB 830 as a potential treat...